Lichen sclerosus in children

Journal of Obstetrics and Gynaecology

Volumn 24, Issue 7, 2004, Pages 733-735

  McLelland, Janet ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; CORTICOSTEROID; HLA B7 ANTIGEN; TACROLIMUS;

CLINICAL FEATURE; CONSTIPATION; DISEASE ASSOCIATION; DYSURIA; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; NOTE; PHIMOSIS; PRIORITY JOURNAL; PRURITUS; VULVECTOMY;

ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; EPIDERMIS; FEMALE; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; MALE; PAPILLOMAVIRIDAE; PROGNOSIS; SKIN; TREATMENT OUTCOME;

EID: 10444276467     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/014436104100009386     Document Type: Note

References (23)

1. Assmann T., Becker-Wegerich P., Grewe M., Megahed M. and Ruzicka T. (2003) Tacrolimus ointment for the treatment of vulvar lichen sclerosus. Journal of the American Academy of Dermatology, 48, 935-937.
2. Berth-Jones J., Graham-Brown R.A.C. and Burns D.A. (1989) Lichen sclerosus. Archives of Disease in Childhood, 64, 1204-1206.
3. Bohm M., Frieling U., Luger T.A. and Bonsmann G. (2003) Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Archives of Dermatology, 139, 922-924.
4. Bornstein J., Heifetz S., Kellner Y., Stolar Z. and Abramovici H. (1998) Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. American Journal of Obstetrics and Gynecology, 178, 80-84.
5. Catterall R.D. and Oates J.K. (1962) Treatment of balanitis xerotica obliterans with hydrocortisone injections. British Journal of Venereal Disease, 38, 75-77.
6. Chalmers R.J.A., Burton P.A., Bennett R.F., Goring C.C. and Smith P.J. (1984) Lichen sclerosus et atrophicus: a common cause of phimosis in boys. Archives of Dermatology, 120, 1025-1027.
7. Dalziel K.L., Millard P.R. and Wojnarowska F. (1991) The treatment of vulvar lichen sclerosus with a very potent topical steroid (clobetasol dipropionate 0.05%). British Journal of Dermatology, 124, 461-464.
8. Davison D.C., Clarke M.D.B. and Kean H.B. (1987) Lichen sclerosus et atrophicus in children misdiagnosed as sexual abuse. British Medical Journal, 295, 211.
9. Drut R.M., Gomez M.A., Drut R. and Lojo M.M. (1998) Human papillomavirus is present in some cases of childhood penile lichen sclerosus; an in situ hybridisation and SP-PCR study. Pediatric Dermatology, 15, 85-90.
10. Fischer G. and Rogers M. (1997) Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid. Pediatric Dermatology, 14, 235-237.
11. Goolamali S.K., Barnes E.W., Irvine W.J. and Shuster S. (1974) Organ specific antibodies in patients with lichen sclerosus. British Medical Journal, 4, 78-79.
12. Marren P., Yell J., Charnock P.M., Bunce M., Welsh K. and Wojnarowska F. (1985) The association between lichen sclerosus and antigens of the HLA system. British Journal of Dermatology, 132, 197-203.
13. Meuli M., Briner J., Hanimann B. and Sacher P. (1994) Lichen sclerosus et atrophicus causing phimosis in boys. A prospective study with 5-year follow-up after complete circumcision. Journal of Urology, 152, 987-989.
14. Meyrick-Thomas R.H., Ridley C.M., Sherwood C.F. and Black M.M. (1984) The lack of association of lichen sclerosus et atrophicus with HLA A and B tissue antigens. Clinical and Experimental Dermatology, 9, 290-292.
15. Oyama N., Chan I., Neill S.M., Hamada T., South A.P., Wessagowit V., Wojnarowska F., D'Cruz D., Hughes G.J., Black M.M. and McGrath J.A. (2003) Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet, 362, 118-123.
16. Powell J., Wojnarowska F., Winsey S., Marren P. and Welsh K. (2000) Lichen sclerosus premenarche; autoimmunity and immunogenetics. British Journal of Dermatology, 142, 481-484.
17. Powell J. and Wojnarowska F. (2001) Childhood vulvar lichen sclerosus; an increasingly common problem. Journal of the American Academy of Dermatology, 44, 803-806.
18. Powell J. and Wojnarowska F. (2002) Childhood vulval lichen sclerosus. The course after puberty. Journal of Reproductive Medicine, 47, 706-709.
19. Powell J., Strauss S., Gray J. and Wojnarowska F. (2003) Genital carriage of human papillomavirus (HPV) DNA in prepubertal girls with and without vulvar disease. Pediatric Dermatology, 20, 191-194.
20. Rolfe K.J., Crow J.C., Reid W.M., Benjamin E., MacLean A.B. and Perrett C.W. (2002) The effect of topical corticosteroids on Ki67 and p53 expression in vulval lichen sclerosus. British Journal of Dermatology, 147, 503-508.
21. Tan S.H., Derrick E., McKee P.H., Hobbs C., Ridley M. and Neill S. (1994) Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus. Journal of Cutaneous Pathology, 21, 316-323.
22. Turner R.J. and McLelland J. (1999) The clinical features and outcome of treatment of lichen sclerosus of the penis. British Journal of Dermatology, 140, 70-71.
23. Warrington S.A. and de San Lazaro C. (1996) Lichen sclerosus et atrophicus and sexual abuse. Archives of Diseases in Childhood, 15, 512-516.